biologics

/Tag: biologics

Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline

2019-08-28T08:54:22+00:00

Metrion Biosciences’ tenth External Speaker Series presentation featured Dr Catherine Hutchings, a highly experienced biologics drug discovery researcher and independent consultant. Dr Hutchings’ presentation included an overview of membrane proteins as drug targets and the evolution of antibody therapeutics technology, spanning isolation of the first mouse monoclonal antibody (mAb) hybridoma to exploitation of the favourable [...]

Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline2019-08-28T08:54:22+00:00

Metrion Biosciences External Speaker Event: Dr Cath Hutchings

2019-06-17T16:14:33+00:00

Metrion Biosciences look forward to welcoming Dr Cath Hutchings to present “Opportunities for ion channel targeting antibodies: current landscape and pipeline” as part of our continuing External Speaker Series on Wednesday 31st July 2019. The event will be held at the Granta Centre, Granta Park. The presentation will start promptly at 13.30 and will be [...]

Metrion Biosciences External Speaker Event: Dr Cath Hutchings2019-06-17T16:14:33+00:00

Cambridge Ion Channel Forum

2018-07-18T16:01:59+00:00

Metrion Biosciences and AstraZeneca joined forces on Tuesday 8th May 2018 to co-host the fifth Cambridge Ion Channel Forum at Medimmune’s Milstein Building on Granta Park, Cambridge (UK). Established in 2011, with previous co-organisers including Neusentis, Medimmune and BioFocus, this afternoon session of ion channel focused presentations provides an opportunity for delegates to participate [...]

Cambridge Ion Channel Forum2018-07-18T16:01:59+00:00